These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17505693)
1. Percutaneous prostate cryoablation as treatment for high-risk prostate cancer. El Hayek OR; Alfer W; Reggio E; Pompeo AC; Arap S; Srougi M Clinics (Sao Paulo); 2007 Apr; 62(2):109-12. PubMed ID: 17505693 [TBL] [Abstract][Full Text] [Related]
2. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694 [TBL] [Abstract][Full Text] [Related]
3. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882 [TBL] [Abstract][Full Text] [Related]
4. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS Perm J; 2019; 23():. PubMed ID: 31050644 [TBL] [Abstract][Full Text] [Related]
5. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. Ng CK; Moussa M; Downey DB; Chin JL J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104 [TBL] [Abstract][Full Text] [Related]
6. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze. Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413 [TBL] [Abstract][Full Text] [Related]
7. Salvage cryoablation for local recurrence of prostatic cancer after curative therapy. Barat M; Colleter L; Mongiat-Artus P; Jolibois Z; Quero L; Hennequin C; Desgrandchamps F; de Kerviler E Diagn Interv Imaging; 2019 Nov; 100(11):679-687. PubMed ID: 31331832 [TBL] [Abstract][Full Text] [Related]
8. Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes. El Hayek OR; Alfer W; Reggio E; Pompeo AC; Arap S; Lucon AM; Srougi M Urol Int; 2008; 81(2):186-90. PubMed ID: 18758217 [TBL] [Abstract][Full Text] [Related]
9. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen. Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721 [TBL] [Abstract][Full Text] [Related]
10. Salvage prostate cryoablation: initial results from the cryo on-line data registry. Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664 [TBL] [Abstract][Full Text] [Related]
11. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685 [TBL] [Abstract][Full Text] [Related]
12. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814 [TBL] [Abstract][Full Text] [Related]
13. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840 [TBL] [Abstract][Full Text] [Related]
14. Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy. Chang X; Liu T; Zhang F; Zhao X; Ji C; Yang R; Gan W; Zhang G; Li X; Guo H Int Urol Nephrol; 2015 Feb; 47(2):301-5. PubMed ID: 25510358 [TBL] [Abstract][Full Text] [Related]
15. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Bahn DK; Lee F; Silverman P; Bahn E; Badalament R; Kumar A; Greski J; Rewcastle JC Clin Prostate Cancer; 2003 Sep; 2(2):111-4. PubMed ID: 15040872 [TBL] [Abstract][Full Text] [Related]
16. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. Ismail M; Ahmed S; Kastner C; Davies J BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081 [TBL] [Abstract][Full Text] [Related]
17. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy. Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004 [TBL] [Abstract][Full Text] [Related]
18. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation. Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170 [TBL] [Abstract][Full Text] [Related]